Post-marketing surveillance, also known as pharmacovigilance, is essential to monitor the safety of drugs after they have been approved for use. Epidemiologists collect and analyze data on adverse drug reactions and other drug-related problems. This ongoing process helps in identifying any long-term or rare side effects that were not apparent during clinical trials.
